Key metrics and charts across all fundamental categories.
Stock price and market valuation
BAX trades at $20.825, a 39.2% decrease year-over-year. Market capitalization stands at $10.72B, down 38.8% from the prior year. Track BAX price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$11.32B in TTM revenue grew 17.1% YoY, reaching $2.70B last quarter. TTM EBITDA of $1.26B on operating income of $66.00M shows growth is flowing through. However, net income is negative at $1.10B — growth is not yet reaching the bottom line. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $19.85B in assets and $8.62B in long-term debt, the D/E of 1.4 reflects moderate leverage — debt is manageable but worth monitoring.
Price multiples and return ratios
P/S of 0.9x and P/B of 1.8x. A low P/S may indicate the stock is undervalued.
Operating efficiency and return metrics
Op. margin of 2.4% is up 0.2% YoY — cost efficiency is improving. Net margin at -0.6% and gross margin of 33.0%. Negative ROE of -18.3% indicates shareholder value is being eroded.
Free cash flow, earnings quality, and capital allocation
FCF of $76.00M on $213.00M in operating cash flow. The FCF / Net Income ratio of -0.1x shows cash consumption — the business is not yet self-funding. Cash reserves of $2.02B provide financial flexibility. Share count is stable — no dilution or buyback activity.
